2021 annual financial data

Gain Therapeutics, Inc. 2021 Net margin

Gain Therapeutics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -8,418.86%.

Operating income was -13,826,173 USD and net income was -13,890,606 USD.
Operating cash flow was -12,365,670 USD.

Get free Gain Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
164,994 USD
Operating income
-13,826,173 USD
Net income
-13,890,606 USD
Operating cash flow
-12,365,670 USD